Estrogen Stimulation of Ovarian Surface Epithelial Cell Proliferation

Overview

Journal In Vitro Cell Dev Biol Anim

Publisher Springer

Specialties Biology
Cell Biology

Date 2001 Mar 7

PMID 11229598

Citations 33

Authors

W Bai

Q Wang

S V Nicosia

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer is the leading cause of gynecological cancer mortality, and 85-90% of this malignancy originates from the ovarian surface epithelium (OSE). The etiology of ovarian epithelial cancer is unknown, but a role for estrogens has been suspected. However, the effect of estrogens on OSE cell proliferation remains to be determined. Using the rabbit model, our studies have demonstrated that 17beta-estradiol stimulates OSE cell proliferation and the formation of a papillary ovarian surface morphology similar to that seen in human ovarian serous neoplasms of low malignant potential. Immunohistochemical staining of ovarian tissue sections with an antibody to the estrogen receptor alpha demonstrates its expression in both OSE cells and stromal interstitial cells. In primary ovarian cell cultures, the proliferative response of the epithelial cells to 17beta-estradiol depends on the expression of the estrogen receptor alpha in the epithelial cells. However, when the epithelial cells are grown together with ovarian stromal cells, their proliferative response to this hormone is greatly enhanced, suggesting the involvement of stromal-epithelial interactions. These studies suggest a role for estrogens and the estrogen receptor alpha in OSE growth.

Citing Articles

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer.

Reichenbach J, Fraungruber P, Mayr D, Buschmann C, Kraus F, Topalov N J Cancer Res Clin Oncol. 2023; 149(11):8719-8728.

PMID: 37131060 PMC: 10374731. DOI: 10.1007/s00432-023-04708-z.

Isolation, culture, and characterisation of bovine ovarian fetal fibroblasts and gonadal ridge epithelial-like cells and comparison to their adult counterparts.

Liu M, Hummitzsch K, Bastian N, Hartanti M, Wan Q, Irving-Rodgers H PLoS One. 2022; 17(7):e0268467.

PMID: 35802560 PMC: 9269465. DOI: 10.1371/journal.pone.0268467.

Microscopic Evaluation of Ovarian Surface Epithelium Following Treatment with Conjugated Estrogens in a Mouse Model.

Al-Amri I, Kadim I, Al-Kindi A, Khalaf S, Al-Harrasi A, Al-Hashmi S Asian Pac J Cancer Prev. 2022; 23(6):1913-1920.

PMID: 35763631 PMC: 9587831. DOI: 10.31557/APJCP.2022.23.6.1913.

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.

Vogelsang T, Vattai A, Schmoeckel E, Kaltofen T, Chelariu-Raicu A, Zheng M Int J Mol Sci. 2021; 22(16).

PMID: 34445181 PMC: 8395182. DOI: 10.3390/ijms22168479.

Carcinogenic effects of bisphenol A in breast and ovarian cancers.

Dumitrascu M, Mares C, Petca R, Sandru F, Popescu R, Mehedintu C Oncol Lett. 2020; 20(6):282.

PMID: 33014160 PMC: 7520752. DOI: 10.3892/ol.2020.12145.

References

Cunha G . Growth factors as mediators of androgen action during male urogenital development. Prostate Suppl. 1996; 6:22-5. View

Pujol P, Rey J, Nirde P, Roger P, Gastaldi M, Laffargue F . Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis. Cancer Res. 1998; 58(23):5367-73. View

Evans R . The steroid and thyroid hormone receptor superfamily. Science. 1988; 240(4854):889-95. PMC: 6159881. DOI: 10.1126/science.3283939. View

Saunders P, Maguire S, Gaughan J, Millar M . Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J Endocrinol. 1997; 154(3):R13-6. DOI: 10.1677/joe.0.154r013. View

Tora L, White J, Brou C, Tasset D, Webster N, Scheer E . The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 1989; 59(3):477-87. DOI: 10.1016/0092-8674(89)90031-7. View

Paech K, Webb P, Kuiper G, Nilsson S, Gustafsson J, Kushner P . Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 1997; 277(5331):1508-10. DOI: 10.1126/science.277.5331.1508. View

Kuiper G, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J . Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A. 1996; 93(12):5925-30. PMC: 39164. DOI: 10.1073/pnas.93.12.5925. View

Ghossain M, Buy J, Ligneres C, Bazot M, Hassen K, Malbec L . Epithelial tumors of the ovary: comparison of MR and CT findings. Radiology. 1991; 181(3):863-70. DOI: 10.1148/radiology.181.3.1947112. View

Isola J, Kallioniemi O, Korte J, Wahlstrom T, Aine R, Helle M . Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol. 1990; 162(4):295-301. DOI: 10.1002/path.1711620404. View

10.

Geisinger K, Berens M, Duckett Y, Morgan T, Kute T, Welander C . The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro. Cancer. 1990; 65(5):1055-61. DOI: 10.1002/1097-0142(19900301)65:5<1055::aid-cncr2820650502>3.0.co;2-9. View

11.

Giacomini G, Nicosia S, Saunders B, FULTZ C, Sun X, Jasonni V . Ovarian mesothelial and extramesothelial cells in interactive culture. In Vitro Cell Dev Biol Anim. 1995; 31(4):300-9. DOI: 10.1007/BF02634005. View

12.

Granberg S, Wikland M, Jansson I . Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol. 1989; 35(2):139-44. DOI: 10.1016/0090-8258(89)90031-0. View

13.

Nash J, Ozols R, Smyth J, Hamilton T . Estrogen and anti-estrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet Gynecol. 1989; 73(6):1009-16. DOI: 10.1097/00006250-198906000-00021. View

14.

Lee H, Jiang F, Wang Q, Nicosia S, Yang J, Su B . MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol Endocrinol. 2000; 14(11):1882-96. DOI: 10.1210/mend.14.11.0554. View

15.

Langdon S, Hawkes M, Lawrie S, Hawkins R, Tesdale A, Crew A . Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines. Br J Cancer. 1990; 62(2):213-6. PMC: 1971801. DOI: 10.1038/bjc.1990.263. View

16.

Tzukerman M, Esty A, Danielian P, Parker M, Stein R, Pike J . Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 1994; 8(1):21-30. DOI: 10.1210/mend.8.1.8152428. View

17.

Cooke P, Buchanan D, Young P, Setiawan T, Brody J, Korach K . Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci U S A. 1997; 94(12):6535-40. PMC: 21085. DOI: 10.1073/pnas.94.12.6535. View

18.

Langdon S, Lawrie S, Hay F, Hawkes M, McDonald A, Hayward I . Characterization and properties of nine human ovarian adenocarcinoma cell lines. Cancer Res. 1988; 48(21):6166-72. View

19.

Tsai M, OMalley B . Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994; 63:451-86. DOI: 10.1146/annurev.bi.63.070194.002315. View

20.

Malet C, Gompel A, Spritzer P, Bricout N, YANEVA H, Mowszowicz I . Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture. Cancer Res. 1988; 48(24 Pt 1):7193-9. View